New warnings have been added to the prescribing information for the Alzheimer's drug Aricept (donepezil) advising of the risk of two rare but potentially serious conditions: muscle breakdown ...

Donepezil oral tablet is available as a brand-name drug and a generic drug. Brand name: Aricept. Donepezil comes in two oral tablet forms: tablet and disintegrating tablet (ODT). Donepezil oral tablet ...

WOODCLIFF LAKE, N.J.--(BUSINESS WIRE)-- Eisai Inc. today announced that the U.S. Food and Drug Administration (FDA) has accepted for review the New Drug Application (NDA) for the Aricept ® Patch ...

Princeton, New Jersey; June 1, 2011 - Sandoz today announced the US Food and Drug Administration (FDA) approval and US launch of donepezil hydrochloride (HCL) film-coated tablets and donepezil HCL ...

The acetylcholinesterase inhibitor donepezil (Aricept) failed to improve chemotherapy-related cognitive impairment (CRCI) in breast cancer survivors, a placebo-controlled trial showed. After 24 weeks ...

March 7, 2012 — The cholinesterase inhibitor donepezil (Aricept, Pfizer), which is widely used to treat mild to moderate Alzheimer's disease (AD), also appears to be beneficial in patients with ...

Donepezil, marketed under the brand name Aricept, is an oral tablet medication prescribed for people living with Alzheimer’s disease. Medicare drug plans may cover the brand drug Aricept or its ...

Review the side-effects of Donepezil as documented in medical literature. The term "side effects" refers to unintended effects that can occur as a result of taking the medication. In majority of the ...

Aricept (donepezil) is a tablet medication prescribed for people living with Alzheimer’s disease. Medicare drug plans may cover Aricept or its generic version, but the exact coverage and a person’s ...

Aricept (donepezil) is a brand-name drug prescribed for dementia related to Alzheimer’s disease. Aricept has interactions with other drugs and certain supplements. Examples include antihistamines and ...

NICE has today (23 March 2011) issued updated guidance to the NHS on the use of four drugs to help manage Alzheimer´s disease. The updated guidance extends previous recommendations for the use of ...

Oral medications may be covered by a stand-alone Medicare Part D plan or a Medicare Advantage Prescription Drug (MAPD) plan. Both types of plans are approved by Medicare but administered by private ...